{"id":62843,"date":"2026-05-06T18:23:40","date_gmt":"2026-05-06T22:23:40","guid":{"rendered":"https:\/\/tvdelmarva.com\/wp\/new-mrna-flu-shot-shows-superior-results-in-major-clinical-trial\/"},"modified":"2026-05-06T18:23:40","modified_gmt":"2026-05-06T22:23:40","slug":"new-mrna-flu-shot-shows-superior-results-in-major-clinical-trial","status":"publish","type":"post","link":"https:\/\/tvdelmarva.com\/wp\/new-mrna-flu-shot-shows-superior-results-in-major-clinical-trial\/","title":{"rendered":"New mRNA Flu Shot Shows Superior Results in Major Clinical Trial"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n

A groundbreaking flu vaccine using mRNA technology has shown significantly better results than traditional shots in a comprehensive clinical trial involving more than 40,000 participants aged 50 and above, according to research published Wednesday.<\/p>

The experimental vaccine from Moderna demonstrated 26.6% greater effectiveness compared to GSK’s conventional standard-dose flu vaccine, surpassing the study’s primary objective of proving non-inferiority to existing immunizations.<\/p>

Federal regulators are currently evaluating the vaccine application, with a final determination anticipated by August 5th. If given the green light, this would mark the first seasonal influenza vaccine in America utilizing mRNA technology, which offers faster development capabilities than traditional manufacturing approaches.<\/p>

However, the approval process faces additional challenges under Health Secretary Robert F. Kennedy Jr., who has expressed strong opposition to mRNA platforms. Kennedy, known for his anti-vaccine stance, has eliminated hundreds of millions in research funding and made unsubstantiated claims about the technology.<\/p>

“These findings support the role of mRNA-1010 in improving influenza prevention,” stated Dr. Isabel Leroux-Roels from Ghent University and her research team in their publication in the New England Journal of Medicine.<\/p>

The study revealed that participants receiving the mRNA vaccine experienced more frequent side effects, including pain at the injection site, tiredness, headaches, and muscle soreness, compared to those getting standard shots. However, most reactions were classified as mild to moderate and resolved quickly.<\/p>

Serious adverse events occurred at similar rates between both groups, affecting 2.2% of mRNA vaccine recipients versus 1.9% of those receiving the conventional vaccine. Researchers noted that overall safety profiles aligned with previous large-scale trial results.<\/p>

The FDA initially declined Moderna’s application in February, questioning the company’s choice to compare against a standard-dose vaccine rather than the high-dose formulation typically recommended for Americans 65 and older due to its superior effectiveness.<\/p>

Following discussions between the company and regulators, the agency accepted a revised application with Moderna’s commitment to conduct additional studies in elderly populations after approval.<\/p>

International regulatory authorities in the European Union, Canada, and Australia are also reviewing the vaccine. Meanwhile, European officials approved Moderna’s combination mRNA vaccine targeting both influenza and COVID-19 in April.<\/p>","protected":false},"excerpt":{"rendered":"

Moderna’s experimental mRNA-based influenza vaccine demonstrated 26.6% better effectiveness than traditional flu shots in a large-scale study of over 40,000 adults. The FDA is reviewing the vaccine application with a decision expected by August 5th, which could make it the first mRNA flu vaccine approved in the United States.<\/p>\n","protected":false},"author":4,"featured_media":62842,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[837],"tags":[],"class_list":["post-62843","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1778106219869.jpg?fit=450%2C300&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/pbtNqq-glB","jetpack-related-posts":[{"id":83496,"url":"https:\/\/tvdelmarva.com\/wp\/fda-panel-to-vote-on-modernas-first-mrna-flu-vaccine-for-older-adults\/","url_meta":{"origin":62843,"position":0},"title":"FDA Panel to Vote on Moderna’s First mRNA Flu Vaccine for Older Adults","author":"Admin","date":"June 18, 2026","format":false,"excerpt":"A federal advisory panel is preparing to vote on whether Moderna's experimental mRNA-based flu vaccine, mFlusiva, is safe and effective enough to approve for adults aged 50 and older. The review comes after a turbulent period at the FDA that included leadership departures tied to controversies over the vaccine's application.\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781777986807.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":22453,"url":"https:\/\/tvdelmarva.com\/wp\/fda-agrees-to-review-modernas-revolutionary-mrna-flu-vaccine-after-public-clash\/","url_meta":{"origin":62843,"position":1},"title":"FDA Agrees to Review Moderna’s Revolutionary mRNA Flu Vaccine After Public Clash","author":"Admin","date":"February 18, 2026","format":false,"excerpt":"Federal health regulators have reversed course and will now evaluate Moderna's groundbreaking mRNA-based influenza vaccine following an unusual public disagreement. The company's stock jumped over 5% after announcing the FDA will consider approval by August 5th.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1771429564957.jpg?fit=1000%2C562&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1771429564957.jpg?fit=1000%2C562&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1771429564957.jpg?fit=1000%2C562&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1771429564957.jpg?fit=1000%2C562&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":83540,"url":"https:\/\/tvdelmarva.com\/wp\/fda-panel-reviews-first-mrna-flu-vaccine-for-adults-50-and-older\/","url_meta":{"origin":62843,"position":2},"title":"FDA Panel Reviews First mRNA Flu Vaccine for Adults 50 and Older","author":"Admin","date":"June 18, 2026","format":false,"excerpt":"Federal health advisers are weighing whether to recommend approval of a first-of-its-kind flu vaccine built on mRNA technology \u2014 the same science behind COVID-19 shots. Moderna is seeking FDA approval of the vaccine, called mFlusiva, for adults aged 50 and older. A favorable FDA review has already been published, with\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781782318606.jpg?fit=1000%2C562&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781782318606.jpg?fit=1000%2C562&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781782318606.jpg?fit=1000%2C562&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781782318606.jpg?fit=1000%2C562&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":78786,"url":"https:\/\/tvdelmarva.com\/wp\/mrna-cancer-vaccines-show-promise-despite-federal-funding-cuts\/","url_meta":{"origin":62843,"position":3},"title":"mRNA Cancer Vaccines Show Promise Despite Federal Funding Cuts","author":"Admin","date":"June 9, 2026","format":false,"excerpt":"The same mRNA technology used in COVID-19 vaccines is demonstrating significant progress against deadly cancers including melanoma, pancreatic, and brain tumors. These advances come despite recent federal cuts to mRNA research programs, with scientists warning that reduced innovation could allow other countries to take the lead in this promising medical\u2026","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781000603487.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":31577,"url":"https:\/\/tvdelmarva.com\/wp\/moderna-stock-jumps-10-after-2-25b-patent-settlement-deal\/","url_meta":{"origin":62843,"position":4},"title":"Moderna Stock Jumps 10% After $2.25B Patent Settlement Deal","author":"Admin","date":"March 4, 2026","format":false,"excerpt":"Moderna's stock price surged 10% in premarket trading Wednesday following the company's settlement of a major patent lawsuit over COVID-19 vaccine technology. The biotech firm will pay up to $2.25 billion to resolve claims it illegally used lipid nanoparticle technology in its coronavirus vaccine.","rel":"","context":"In "Business"","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1772634129094.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":55347,"url":"https:\/\/tvdelmarva.com\/wp\/federal-court-ruling-leaves-vaccine-guidance-panel-frozen-covid-shots-uncertain\/","url_meta":{"origin":62843,"position":5},"title":"Federal Court Ruling Leaves Vaccine Guidance Panel Frozen, COVID Shots Uncertain","author":"Admin","date":"April 21, 2026","format":false,"excerpt":"A federal judge has halted the work of the CDC's vaccine advisory committee after ruling that most panel members appointed by Robert F. Kennedy Jr. were unqualified. The decision leaves Americans without clear guidance for upcoming COVID and flu shots, and raises questions about insurance coverage for new vaccines.","rel":"","context":"In "Health"","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/04\/news-1776767148006.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/62843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/comments?post=62843"}],"version-history":[{"count":0,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/62843\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media\/62842"}],"wp:attachment":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media?parent=62843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/categories?post=62843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/tags?post=62843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}